BTX
NYSE
$8.42
BlackRock Innovation and Growth Term Trust (BTX)
Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. The company is headquartered in Brooklyn, New York.
Sector:
Financial Services
Industry:
Asset Management
Target: $3 (-64.37%)
Market Cap
$977M
Dividends 5Y CAGR
+30.67%
P/E Ratio
27.00
Free Cash Flow Yield
-1.78%
Price Chart
Valuation
Market Cap$977M
P/E27.00
P/S85.28
P/B1.07
Profitability
Total Revenue (TTM)$598K
EBITDA-$39M
EPS$0.31
Financial Health
Free Cash Flow Yield-1.78%
Growth & Risk
Revenue 5Y CAGR-24.67%
FCF 5Y CAGR-12.43%
Dividends 5Y CAGR+30.67%
Beta (5Y)1.26
Sharpe Ratio0.77